The complaint alleges that the deceased’s untimely death was caused by Xarelto. The complaint also alleges that if the plaintiff and her father were aware of the true risks of an uncontrollable internal bleed, they would have not chosen Xarelto for his treatment because of the safer alternatives available on the market. Finally, they allege the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, a subdivision of Johnson&Johnson, were reckless and negligent by putting the drug to market, which was the proximate cause of the injuries and death of the deceased.
New Xarelto Lawsuit Filed in VermontA Xarelto lawsuit was recently filed in Vermont federal court alleging that Xarelto caused a man's uncontrollable internal bleeding and death. In the past year, there has been a rising number of lawsuits filed against the manufacturers of a blood thinner drug called Xarelto. One of the notable lawsuits was filed on July 25, 2014 in Vermont federal court under the case number 2:14-CV-00159-CR. The full complaint can be downloaded and read here.
The lawsuit is brought to court by the daughter of the deceased, who is also based in Vermont. She is the administrator of the deceased’s estate and is seeking compensation for pain and suffering, medical expenses, attorney’s fees, probate, funeral and burial expenses, and other expenses that are related to the deceased’s treatment and administration of his estate.
Xarelto Lawsuit AllegationsThis particular lawsuit was filed by the daughter of a deceased man from Vermont who was prescribed Xarelto because of his atrial fibrillation, a heart condition that can cause blood clots and stroke. The complaint details that the deceased was prescribed Xarelto by his doctor on July 17, 2012. He continued to take the medication until he was hospitalized for an injury and diagnosed with a parenchymal hemorrhage. The deceased still had Xarelto active in his system, so during the hemorrhage his blood did not clot. After six days of hospitalization, the deceased passed away from an uncontrollable internal bleeding event on August 1, 2012.
Xarelto's Dangerous DefectThe lawsuits allege that Xarelto is a much more dangerous drug than other blood thinners on the market because Xarelto does not come with a corresponding antidote. This means that if a patient suffers from an internal bleeding event, there is no medical way available, short of extreme life saving measures, to stop the bleeding. This is in sharp contrast to the situation that patients who take Warfain are in. If a patient taking Warfarin suffers from an internal bleed, a doctor will be able to administer vitamin K and the blood will clot again. Many lawsuits allege that Xarelto’s manufacturers were aware of this dangerous defect with the drug and yet put it to market anyway. The FDA has issued several warnings in regards to Xarelto, a list of which can be found here.
“As the Xarelto litigation progresses, we expect to see even more cases filed.” Xarelto attorney Marc Goldich said “Those who have been harmed by Xarelto deserve justice, do not hesitate to contact us if you feel that you have a case against the manufacturers of this drug.”For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.